PainReform (PRFX) Expected to Announce Quarterly Earnings on Thursday

PainReform (NASDAQ:PRFX) is expected to be announcing its earnings results before the market opens on Thursday, March 6th. Analysts expect the company to announce earnings of ($4.74) per share for the quarter.

PainReform Stock Performance

Shares of PRFX opened at $3.10 on Tuesday. The business’s 50-day moving average is $3.25 and its two-hundred day moving average is $2.86. The company has a market capitalization of $449,500.00, a P/E ratio of -0.02 and a beta of 0.64. PainReform has a fifty-two week low of $1.73 and a fifty-two week high of $61.20.

About PainReform

PainReform Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and second trial for pain treatment of hernia repair operations.